RSV Antigen Rapid Test

The RSV antigen rapid test is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute RSV virus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.

PRL Rapid Quantitative Test (Chemiluminescence Immunoassay)

PRL Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Prolactin (PRL) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

3 in 1(FSH/LH/PRL) Rapid Quantitative Test

The 3- in- 1 test kit can quickly detect hormone levels, shorten the test time and test steps, and reduce doctors' workload

2 in 1(CRP/SAA) Rapid Quantitative Test

Biotime 2 in 1 test kit can help the operator to distinguish the bacterial infection and viral infection, and improve the accuracy of clinical diagnosis of infectious diseases.

CK-MB Rapid Quantitative Test (Chemiluminescence Immunoassay)

CK-MB Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Creatine kinase-MB (CK-MB) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

tPSA Rapid Quantitative Test

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood.

Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay)

Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the lipoprotein-associated phospholipase A2 (Lp-PLA2) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.